Diligence memo · auto-generated · as of July 1, 2026

MID Labs Ltd.

MID Labs Ltd. looks under-valued against its niche peers and is active on financing cadence.

SourceModeled below same-niche peers while still financing on rhythm — a potential mispricing worth a closer look.

Businessfiled

MID Labs Ltd. operates in Biotechnology, based in SAN LEANDRO.

No verified homepage on file yet — operating evidence is limited to the public record.

Capital & rounds (filed)filed

MID Labs Ltd. has raised $4.8M in disclosed capital across 1 recorded round, aggregated from public filings. Its latest round is modeled as Series A (a $4.0M–$15M round).

Largest single filing: $4.8M on —.

Valuation (modeled)modeled

Provath models MID Labs Ltd. at approximately $9.5M (range $5.2M–$13M). This is an algorithmic estimate from round sizes and same-niche peers — not a quoted or reported figure.

Read: Under-valued. Modeled value is 0.10× the median modeled value of Series A Biotechnology companies (1089 peers) — value vs value, same stage and era.

Financing rhythm & timingmixed

No dated round to assess.

Comparablesmixed

Capital scale ranks ahead of 42% of Biotechnology peers (4291 compared).

Modeled value ranks above 18% of those peers.

Peoplefiled

6 named people on file across officers, directors and signatories.

Risks & flagsmixed

No clearly named CEO/founder/principal in the surfaced records — key-person evidence is thin.